AI tool for diagnosing HFpEF heart failure
Part of Heart & circulation clinical trials.
This trial is testing a new AI-powered tool to help doctors better diagnose a specific type of heart failure called HFpEF, where the heart pumps normally but doesn't relax properly. It may help you if you have symptoms like shortness of breath or swelling and your heart ultrasound shows normal pumping ability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with or are suspected to have a type of heart failure called HFpEF (your heart pumps normally but does not relax properly)
- You have had at least one symptom of heart failure, such as shortness of breath, tiredness, nausea, or swollen legs
- You are not currently in the hospital for acute heart failure or sudden worsening of heart failure
- You do not have a severe heart artery blockage (over 75%) that hasn't been treated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a combination of biomarkers can help personalize treatment for people with a specific type of heart failure called HFpEF (or heart failure with preserved ejection fraction). It aims to find better treatments based on your individual test results.
This study uses artificial intelligence to analyze heart ultrasounds from people hospitalized with heart failure. It aims to see if AI can help doctors better measure heart function and guide treatment.
This study looks at how the heart muscle works in people with a type of heart failure where the heart pumps normally but doesn't fill properly. It aims to understand the cause better, which could lead to new treatments.
This study is testing better ways to understand and manage heart failure where the heart pumps normally but still doesn't work as well as it should. It looks at people with symptoms like shortness of breath and fatigue, using blood tests and heart imaging to check eligibility.
This study uses different heart imaging tests to help screen for HFpEF (heart failure with preserved pumping strength), make the diagnosis, and estimate your future risk. You may benefit by getting a clearer diagnosis and a better risk picture based on the scans.
This trial tests whether artificial intelligence can help doctors spot cardiac amyloidosis (a protein buildup in the heart) using heart ultrasound images. If you have signs of a thickened heart wall and possible amyloidosis, this study could help confirm your diagnosis faster and more accurately.
Hear when a new Heart Failure With Preserved Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.